ライフサイエンスコーパス: urologic

1 nt noncardiac surgery, with abdominal (36%), urologic (21%), orthopedic (15%), and vascular being mos

2 end-stage renal failure as a consequence of urologic abnormalities (mean age 32 years).

3 ssue of radiologic evaluation for underlying urologic abnormalities following a urinary tract infecti

4 re immunocompromised, and 45% had underlying urologic abnormalities.

5 ng healthy women and persons with underlying urologic abnormalities.

6 promised, and 46% of patients had underlying urologic abnormalities.

7 igestive and nutritional disorders, obesity, urologic and benign hematologic conditions, and, notably

8 , we look at the most recent findings in the urologic and psychiatric literature and try to piece tog

9 c, plastic, podiatric, thoracic, transplant, urologic, and peripheral vascular.

10 mperidone, anticholinergics, loop diuretics, urologics, and ophthalmics.

11 because of the high incidence of associated urologic anomalies.

12 This article details the diverse urologic applications of tissue glues and hemostatic age

13 nical translational research directed toward urologic applications.

14 ica, American Urologic Association, Canadian Urologic Association, and American Urogynecologic Societ

15 ctious Diseases Society of America, American Urologic Association, Canadian Urologic Association, and

16 he European Association of Urology, American Urologic Association, International Continence Society,

17 Cryptorchidism is the most common urologic birth defect in men and is a predisposing facto

18 quality could potentially reduce the risk of urologic cancer and alleviate its burden.

19 The pan-urologic cancer genomic subtypes would facilitate inform

20 as evaluated using three genomic profiles of urologic cancer patients.

21 -hospital mortality after two of three major urologic cancer procedures is affected only by procedure

22 living in urban areas [75%]) received major urologic cancer surgery between Q1 of 2016 and Q2 of 202

23 d translate into better outcomes after major urologic cancer surgery.

24 Comparison of outcome after three major urologic cancer-related surgical procedures (radical cys

25 enal cell carcinoma (RCC) is the most lethal urologic cancer.

26 r framework is not specifically designed for urologic cancers and can be generally applicable for var

27 Here, we show that 1954 urologic cancers can be classified into nine major genom

28 ogist is associated with lower mortality for urologic cancers in that county, but increasing urologis

29 Urologic cancers include cancers of the bladder, kidney,

30 h-volume centers - lymph node dissection for urologic cancers is equivalent between open and minimall

31 s, The Sidney Kimmel Center for Prostate and Urologic Cancers, and the National Institutes of Health

32 For ENT, liver, and urologic cancers, because the trend was different before

33 ecause they are the first care providers for urologic cancers, can easily be identified from availabl

34 arcinoma (RCC) is one of the most aggressive urologic cancers, however, the mechanism on supporting R

35 cers, -5.3% for liver cancers, and -2.9% for urologic cancers.

36 athways as predictive prognostic features in urologic cancers.

37 geneous and is the most lethal cancer of all urologic cancers.

38 roductive technology may allow men to bypass urologic care in order to achieve their family planning

39 al valves and optimized transitions to adult urologic care.

40 disease (AOR, 1.65), black race (AOR, 0.44), urologic cause of ESRD (AOR, 0.57), age >85 years (AOR,

41 Urologic chronic pelvic pain syndrome (UCPPS), which enc

42 mes for future randomized clinical trials in urologic chronic pelvic pain syndrome.

43 c pain syndrome, collectively referred to as urologic chronic pelvic pain syndrome.

44 placebo-controlled trial was conducted at 20 urologic clinics to evaluate the effects of sildenafil t

45 widely diagnosed conditions in men attending urologic clinics.

46 veillance is gaining wider acceptance in the urologic community as an effective treatment option for

47 yperplasia with increased attention from the urologic community in recent years.

48 dardization of pelvic lymphadenectomy in the urologic community is strongly needed.

49 continued to rapidly disseminate through the urologic community, but the ultimate impact remains unde

50 chniques are safely adaptable in the broader urologic community.

51 pathologic conditions increased the risk of urologic complication and vesicoureteral reflux.

52 Because of the high urologic complication rates, careful surveillance of low

53 study was to compare the incidence of major urologic complications (MUCs: urinary leak and ureteric

54 Nine (6.1%) patients had urologic complications and seven (4.8%) patients develop

55 Posttransplant urologic complications are associated with substantially

56 Although urologic complications are higher when kidneys are trans

57 Urologic complications can be avoided.

58 Urologic complications cause substantial morbidity in th

59 Patients with urologic complications had equivalent graft survival, bu

60 by LDN, and a potential higher incidence of urologic complications in LDN transplant recipients.

61 There have been no short-or long-term urologic complications in this series.

62 may have utility in reversing the secondary urologic complications of type 2 diabetes.

63 surgery is associated with increased risk of urologic complications posttransplant.

64 t, it is associated with a high frequency of urologic complications, including urinary tract infectio

65 nd stent use did not affect the incidence of urologic complications.

66 ysfunctional lower urinary tract experienced urologic complications.

67 ificantly fewer urinary tract infections and urologic complications.

68 hange may be important in the development of urologic conditions in aging men.

69 Many urologic conditions that necessitate reconstructive surg

70 Many urologic conditions that require reconstructive surgery

71 o study the neurobiological underpinnings of urologic conditions.

72 ring that of extirpative surgery for certain urologic conditions.

73 Since its initial urologic description in 2007, there has been a surge of

74 on is critical for the child with associated urologic disease and end-stage renal disease.

75 is the most frequently diagnosed kidney and urologic disease and Escherichia coli is by far the most

76 is the most frequently diagnosed kidney and urologic disease, and Escherichia coli is by far the mos

77 asive techniques have been widely applied to urologic diseases affecting the upper and lower urinary

78 Urolithiasis is one of the most common urologic diseases in industrialized societies.

79 Patients with urologic diseases often experience financial toxicity, d

80 ductive failure may be a harbinger of future urologic diseases, including prostate cancer (CaP), thus

81 /Bladder Pain Syndrome (IC/BPS) is a chronic urologic disorder characterized by bladder and/or pelvic

82 Despite being a common urologic disorder with potentially complicated sequela,

83 ic antagonist for the treatment of pediatric urologic disorders has expanded greatly over the past de

84 stinctive urinary crystals and a spectrum of urologic disorders were noted in patients receiving indi

85 he endoscopic treatment of a wide variety of urologic disorders.

86 n the treatment of benign and some malignant urologic disorders.

87 sociated with Fournier gangrene (FG), a rare urologic emergency characterized by necrotizing infectio

88 91 eligible patients, 85 underwent complete urologic evaluation and 68 (75%; 95% confidence interval

89 thus emphasizing the importance of dedicated urologic evaluation and care for all male infertility pa

90 Mean number of years between urologic evaluation and herniorrhaphy was 6.3 years.

91 DVICE 4: Clinicians should refer for further urologic evaluation in all adults with gross hematuria,

92 After complete urologic evaluation, operable patients who achieved comp

93 This review critically assesses some of the urologic evaluations in patients who have undergone feta

94 sion before 35 years of age: 2 points; first urologic event before 35 years of age: 2 points; PKD2 mu

95 yed their widespread implementation into the urologic field.

96 Men with PI-RADS categories 1-2 remained in urologic follow-up for at least 2 years, with rebiopsy (

97 The importance of associated urologic, gynecologic, neurologic, and orthopedic malfor

98 rom 86.0% for orthopedic surgery to 53.8% in urologic/gynecologic and 53.6% in other procedures.

99 13 patients with abnormal VCUGs had a prior urologic history.

100 orthopedic, neurosurgical, gynecologic, and urologic) in adult patients with low surgical risk (defi

101 Urologic injuries result in substantial morbidity.

102 ctive analysis of taTME cases complicated by urologic injury was conducted.

103 high likelihood of calculi who would require urologic intervention within 90 days.

104 all, 46 of 264 (17.4%) of patients underwent urologic intervention, and 25 of 108 (23.1%) patients wh

105 ion regimens, the role of minimally invasive urologic intervention, and the recent insights into the

106 identify patients in the ED who will require urologic intervention.

107 ts who underwent reduced-dose CT underwent a urologic intervention; all were correctly diagnosed on t

108 to improve performance of a wider variety of urologic interventions beyond the standard minimally inv

109 Image-guided surgery (IGS) for abdominal and urologic interventions presents complex engineering and

110 outcomes is an underexplored area within the urologic literature and can provide an insight into a pa

111 parallels the time in which patients in the urologic literature develop adenocarcinomas after bladde

112 To review the recent urologic literature with a focus on refinements of surgi

113 rt site metastasis have been reported in the urologic literature.

114 on, optimal management of, and screening for urologic malignancies in kidney transplant patients is w

115 he incidence, surveillance, and treatment of urologic malignancies in kidney transplant recipients.

116 rm complications of transplantation, such as urologic malignancies, have become increasingly importan

117 Excluding procedures for gynecologic/urologic malignancies, the proportion of procedures perf

118 ging, detection and treatment monitoring for urologic malignancies.

119 est for survivors of upper GI, leukemia, and urologic malignancies.

120 an independent factor for the development of urologic malignancy after KT.

121 All KT recipients who developed urologic malignancy from January 1, 1999, to December 31

122 High urologic malignancy incidence has been reported in end-s

123 The cumulative urologic malignancy incidence rate was significantly hig

124 pients tended to have a significantly higher urologic malignancy risk after KT.

125 Incidence rate ratio of urologic malignancy was significantly higher in female r

126 e relative odds (odds ratios) of an abnormal urologic measure in men with high versus low serum IGF-I

127 Urologic measures were assessed from the International P

128 stment for IGF-I and age, but not with other urologic measures.

129 s, hypertension, ischemia, acute injury, and urologic obstructive disorders), persistently elevated r

130 cell carcinoma remains a major challenge for urologic oncologists.

131 integration of palliative care into surgical urologic oncology and should be aware of palliative care

132 for palliative care use and how the field of urologic oncology can adopt best practices.

133 ciety for Radiation Oncology, and Society of Urologic Oncology to conduct a systematic review of the

134 otic surgery has gained a strong foothold in urologic oncology, gynecologic oncology, cardiothoracic

135 of minimally invasive surgical techniques in urologic oncology, the efficacy, safety, and adequacy of

136 Given the paucity of data on this topic in urologic oncology, we sought to quantify the enrollment

137 d in the less chaotic arena of, for example, urologic oncology.

138 f of the the Italian Network for Research in Urologic-Oncology (Meet-URO 2).

139 om 324 study centres (ie, hospitals or large urologic or group outpatient offices) in 43 countries.

140 tions in probands and FDRs who were blind to urologic or psychiatric diagnoses in the proband.

141 an operation performed by general, vascular, urologic, or cardiac surgery services between fiscal yea

142 Contrariwise, 1297 patients undergoing urologic, orthopedic, breast, and skin operations had mo

143 the effects of such a repair with respect to urologic outcome.

144 een hormone variables and rates of change in urologic outcomes were assessed with linear regression m

145 Annual changes in hormone levels and urologic outcomes were calculated using mixed-effects re

146 s contribute to the rates of change in these urologic outcomes.

147 ested possible central processes involved in urologic pain conditions similar to systemic pain syndro

148 Urologic pain conditions such as chronic prostatitis/chr

149 to map different phenotypes in patients with urologic pain conditions to tailor more effective therap

150 Domain characterization of urologic pain conditions via phenotype mapping can be us

151 nt literature on phenotype classification in urologic pain patients and their use in providing effect

152 In 2005, the International Society of Urologic Pathology consensus conference recommended that

153 following the 2005 International Society of Urologic Pathology consensus conference, AS may be appro

154 ncer was defined as International Society of Urologic Pathology grade group (GG) 1 clinical tumor sta

155 a major cause of morbidity and anxiety among urologic patients.

156 Urologic physiologic examinations were performed.

157 onditions traditionally outside the scope of urologic practice but important for the care of men with

158 1987 and 1997, when screening became routine urologic practice in the United States.

159 s are being increasingly employed in current urologic practice.

160 well characterized by direct interview, the urologic problems had been found only via medical histor

161 ly more likely to have PD, thyroid disorder, urologic problems, and any of the syndrome disorders (co

162 rated that CT is the test of choice for many urologic problems, including urolithiasis, renal masses,

163 nists in the management of various pediatric urologic problems.

164 ency department visit, hospitalization, or a urologic procedure to investigate or manage gross hematu

165 icted worse outcomes and performing an early urologic procedure was a protective measure.

166 milar to findings for patients who underwent urologic procedures (7 tablets [IQR, 5-10 tablets] vs 1

167 are still large variations in the prices of urologic procedures among academic hospitals and by insu

168 study that determined the prices of 5 common urologic procedures among academic medical centers and b

169 ds robotic surgery, particularly dominant in urologic procedures and rapidly adopted for complex oper

170 (aged 18 years) who underwent orthopedic and urologic procedures and received postoperative prescript

171 ption in early 2000, robotic assistance with urologic procedures continues to expand.

172 strointestinal anastomoses, plastic surgery, urologic procedures including heminephrectomy, and other

173 ospitals performing a high volume of general urologic procedures or unrelated complex procedures may

174 ncy department visits, hospitalizations, and urologic procedures to manage gross hematuria).

175 The mean (SD) pain score on day 4 after urologic procedures was 3.48 (2.43), with a mean (SD) ch

176 The 5 most common urologic procedures were cystourethroscopy, prostate bio

177 , urinary tract abnormalities, or history of urologic procedures were excluded.

178 lude pregnant women and patients who undergo urologic procedures with risk of mucosal injury.

179 edic procedures and 77 [43.5%] who underwent urologic procedures).

180 Among those who underwent urologic procedures, 145 (84.8%) were men, 138 (80.7%) w

181 apply them to the application of robotics to urologic procedures.

182 n an individual prior to undergoing invasive urologic procedures.

183 hopedic procedures and 177 (19.2%) underwent urologic procedures.

184 y able to control pain) after orthopedic and urologic procedures.

185 virtually all extirpative and reconstructive urologic procedures.

186 at which they were seen by a combination of urologic, radiation, and medical oncologists in a concur

187 Previous urologic reconstruction and pretransplant ureteral patho

188 obotic surgeons have described techniques in urologic reconstruction.

189 and the need for versatility in vascular and urologic reconstructions.

190 Recent changes in pediatric urologic reconstructive surgery are discussed in the pre

191 th particular emphasis on considerations for urologic referral.

192 within the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) enrolled at 43 urol

193 unity-based Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry and 19,265

194 data to the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry.

195 ed from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a disease registry

196 racted from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), patients were comp

197 unity-based Cancer of the Prostate Strategic Urologic Research Endeavor [CaPSURE]; enrolled 1995 thro

198 ting in the Cancer of the Prostate Strategic Urologic Research Endeavor and who were followed for an

199 As laparoscopic training is integrated into urologic residency programs, standardizing the variables

200 e purpose of this study is to review current urologic robots and present future development direction

201 yond the standard minimally invasive robotic urologic surgeries conducted currently with the da Vinci

202 positive associations with burnout were: (1) urologic surgery (OR 1.497, P = 0.0086), (2) having 31%

203 To review optical imaging technologies in urologic surgery aimed to facilitate intraoperative imag

204 nd platforms designed for minimally invasive urologic surgery and their design rationale and potentia

205 acic, neurosurgery, orthopedic, general, and urologic surgery had received the Checklist.

206 The use of robotics in urologic surgery has seen exponential growth over the la

207 e feasibility and outcomes of reconstructive urologic surgery in older adults.

208 Prior urologic surgery is associated with increased risk of ur

209 The field of reconstructive pediatric urologic surgery is constantly changing.

210 cialties including general, gynecologic, and urologic surgery led to significant improvements in post

211 tted to the general, vascular, thoracic, and urologic surgery services were monitored for the develop

212 gies that have reached the clinical arena in urologic surgery were reviewed, including photodynamic d

213 Robotic urologic surgery, an exciting and new emerging frontier

214 n of this technology to the armamentarium of urologic surgery.

215 ral epithelial cells obtained at the time of urologic surgery.

216 al surgery, peripheral vascular surgery, and urologic surgery.

217 the cost-effectiveness of using robotics in urologic surgery.

218 nique within the field of minimally invasive urologic surgery.

219 ale and potential roles in advancing current urologic surgical practice.

220 r to undergo neurosurgical (9.8% vs 6.2%) or urologic surgical procedures (5.9% vs 2.0%).

221 adults undergoing general, gynecologic, and urologic surgical procedures between 2008 and 2015 (N =

222 l manuscripts on a variety of robot-assisted urologic surgical procedures in children were identified

223 g use of opioids after common orthopedic and urologic surgical procedures through a text messaging sy

224 the evidence suggests that S repens improves urologic symptoms and flow measures.

225 ic antigen level and the association between urologic symptoms and prostate volume-results from the o

226 ant questions related to prostate cancer and urologic symptoms in a data set with missing values.

227 tween over-the-counter NSAID use and certain urologic symptoms, particularly among women with arthrit

228 ess questions related to prostate cancer and urologic symptoms.

229 patients receiving indinavir (8%) developed urologic symptoms.

230 es, and clinical evaluation of patients with urologic symptoms.

231 The urologic team performed MRI of the prostate (Figs 1-4).

232 The urologic team performed MRI of the prostate.

233 on, acute (grade 3 or 4) gastrointestinal or urologic toxicities occurred in 66 with cisplatin (19.1%

234 The frequency and longevity of urologic toxicity associated with cyclophosphamide thera

235 K polyomavirus (BKPyV) in the development of urologic tract malignancies in kidney transplant recipie

236 iocellular carcinoma (CCC; n = 40, 8.0%), or urologic tumors (URO; n = 14, 2.8%).

237 olangiocellular carcinoma [n = 40, 8.0%], or urologic tumors [n = 14, 2.8%]).

238 Thermal ablation of urologic tumors in the form of freezing (cryoablation) a